NCT00632632View on ClinicalTrials.gov

Virtual Reality & D-cycloserine (DCS) for Posttraumatic Stress Disorder (PTSD)

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Posttraumatic Stress Disorder
Interventions
DRUG

D-Cycloserine

Cognitive behavioral treatment (CBT) including prolonged exposure enhanced by virtual reality with D-Cycloserine -100 mg on days when receiving exposure with virtual reality (approximately 10-12 times)

OTHER

Placebo

Cognitive behavioral treatment (CBT) including prolonged exposure enhanced by virtual reality. Placebo given on days when receiving exposure with virtual reality (approximately 10-12 times).

Trial Locations (1)

10065

Weill Cornell Medical College, New York

All Listed Sponsors
lead

Weill Medical College of Cornell University

OTHER

NCT00632632 - Virtual Reality & D-cycloserine (DCS) for Posttraumatic Stress Disorder (PTSD) | Biotech Hunter | Biotech Hunter